Atractylodes (Atractylodes macrocephala)

Atractylodes macrocephala is a traditional Chinese medicine herb containing bioactive compounds like atractylon and atractylenolides that modulate immune function and provide hepatoprotective effects. The herb demonstrates antioxidant, antitumor, and immunomodulatory properties through multiple cellular pathways.

Origin & History

Atractylodes macrocephala, also known as Baizhu, is a perennial herb native to China, with its rhizome used in traditional Chinese medicine. It is primarily harvested for its bioactive components through methods like ultrasonic-assisted extraction and microwave-assisted extraction.

Historical & Cultural Context

In traditional Chinese medicine, Atractylodes macrocephala has been used for centuries to strengthen the spleen, benefit qi, dry dampness, and prevent miscarriage. Its applications are deeply rooted in ancient Chinese herbal practices.

Health Benefits

• Immunomodulation: Exhibits immune-boosting properties in preclinical studies.
• Antitumor Effects: Demonstrated antitumor activities in animal and in vitro studies.
• Antioxidant Activity: Acts as an antioxidant according to preclinical research.
• Hepatoprotection: Offers liver protection in animal models.
• Gastrointestinal Protection: Supports gastrointestinal health, evidenced by preclinical data.

How It Works

Atractylodes macrocephala's bioactive compounds, particularly atractylenolides I-III and atractylon, modulate immune function by enhancing macrophage activity and cytokine production. The herb's hepatoprotective effects involve activation of antioxidant enzymes like superoxide dismutase and glutathione peroxidase while inhibiting inflammatory pathways including NF-κB signaling.

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs are available for Atractylodes macrocephala. Current evidence is based on preclinical studies primarily involving animal and in vitro models.

Clinical Summary

Current research on Atractylodes macrocephala consists primarily of preclinical studies using animal models and in vitro cell cultures. Animal studies have shown immune enhancement effects at doses of 200-400mg/kg body weight, with significant increases in white blood cell counts and antibody production. Hepatoprotective studies in rats demonstrated 40-60% reduction in liver enzyme markers when administered alongside hepatotoxic agents. However, human clinical trials are limited and more research is needed to establish therapeutic efficacy in humans.

Nutritional Profile

Atractylodes macrocephala (Bai Zhu) rhizome is primarily valued for its bioactive compounds rather than conventional macronutrients. Key constituents include: Polysaccharides (AMPs: Atractylodes macrocephala polysaccharides) at approximately 15–45% dry weight, representing the primary immunomodulatory fraction. Volatile oils comprise 1.0–1.5% of the dried rhizome, dominated by atractylone (a sesquiterpene ketone, ~20–30% of volatile fraction), β-eudesmol (~15–20%), and atractylenolides I, II, and III (lactone compounds, collectively ~0.1–0.5% dry weight) — these are the principal antitumor and anti-inflammatory bioactives. Inulin-type fructooligosaccharides are present at roughly 10–20% dry weight, contributing prebiotic and gastrointestinal-supportive effects. Crude fiber content is approximately 10–15% dry weight. Protein content is low at ~5–8% dry weight, with limited bioavailability after typical preparation. Fat content is minimal at ~2–3% dry weight. Micronutrients include modest levels of potassium (~300–400 mg/100g dried), calcium (~100–150 mg/100g), magnesium (~50–80 mg/100g), and trace iron (~5–10 mg/100g). Vitamin content is negligible after drying and decoction processing. Bioavailability note: Atractylolides and polysaccharides show enhanced extraction in hot-water decoction (traditional preparation); lipophilic atractylone is better extracted in ethanolic preparations. Oral bioavailability of atractylenolide I is estimated at 20–40% based on rodent pharmacokinetic studies, with significant first-pass hepatic metabolism.

Preparation & Dosage

No clinically studied dosage ranges for extracts, powders, or standardized forms are specified due to the absence of human trials. Traditional TCM use employs decoctions without quantified standardization. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Reishi, Ginseng, Licorice, Astragalus, Ginger

Safety & Interactions

Atractylodes macrocephala is generally considered safe when used appropriately, though mild gastrointestinal upset may occur in some individuals. The herb may interact with immunosuppressive medications due to its immune-stimulating properties, potentially reducing their effectiveness. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use as the herb's immunomodulatory effects could potentially exacerbate these conditions.